138 related articles for article (PubMed ID: 22559978)
1. Cytogenetic characterization of the murine bladder cancer model MB49 and the derived invasive line MB49-I.
Fabris VT; Lodillinsky C; Pampena MB; Belgorosky D; Lanari C; Eiján AM
Cancer Genet; 2012 Apr; 205(4):168-76. PubMed ID: 22559978
[TBL] [Abstract][Full Text] [Related]
2. Novel invasive orthotopic bladder cancer model with high cathepsin B activity resembling human bladder cancer.
Lodillinsky C; Rodriguez V; Vauthay L; Sandes E; Casabé A; Eiján AM
J Urol; 2009 Aug; 182(2):749-55. PubMed ID: 19539312
[TBL] [Abstract][Full Text] [Related]
3. Nonrandom chromosomal changes in transitional cell carcinoma of the bladder.
Gibas Z; Prout GR; Connolly JG; Pontes JE; Sandberg AA
Cancer Res; 1984 Mar; 44(3):1257-64. PubMed ID: 6692407
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
[TBL] [Abstract][Full Text] [Related]
5. Novel recurrent structural chromosomal aberrations in primary bladder cancer.
Panani AD; Ferti AD; Raptis SA; Roussos C
Anticancer Res; 2004; 24(5A):2967-74. PubMed ID: 15517903
[TBL] [Abstract][Full Text] [Related]
6. Molecular cytogenetic characterization of pancreas cancer cell lines reveals high complexity chromosomal alterations.
Griffin CA; Morsberger L; Hawkins AL; Haddadin M; Patel A; Ried T; Schrock E; Perlman EJ; Jaffee E
Cytogenet Genome Res; 2007; 118(2-4):148-56. PubMed ID: 18000365
[TBL] [Abstract][Full Text] [Related]
7. Chromosomal and proteome analysis of a new T24-based cell line model for aggressive bladder cancer.
Makridakis M; Gagos S; Petrolekas A; Roubelakis MG; Bitsika V; Stravodimos K; Pavlakis K; Anagnou NP; Coleman J; Vlahou A
Proteomics; 2009 Jan; 9(2):287-98. PubMed ID: 19105184
[TBL] [Abstract][Full Text] [Related]
8. Toward the validation of aneusomy detection by fluorescence in situ hybridization in bladder cancer: comparative analysis with cytology, cytogenetics, and clinical features predicts recurrence and defines clinical testing limitations.
Zhang FF; Arber DA; Wilson TG; Kawachi MH; Slovak ML
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2317-28. PubMed ID: 9815630
[TBL] [Abstract][Full Text] [Related]
9. Numerical chromosome 1, 7, 9, and 11 aberrations in bladder cancer detected by in situ hybridization.
Hopman AH; Moesker O; Smeets AW; Pauwels RP; Vooijs GP; Ramaekers FC
Cancer Res; 1991 Jan; 51(2):644-51. PubMed ID: 1985781
[TBL] [Abstract][Full Text] [Related]
10. Consistent chromosome abnormalities associated with mouse bladder epithelial cell lines transformed in vitro.
Cowell JK
J Natl Cancer Inst; 1980 Nov; 65(5):955-61. PubMed ID: 6776328
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetic profile of locally advanced and metastatic Schistosoma-related bladder cancer and response to chemotherapy.
Aly MS; Khaled HM; Emara M; Hussein TD
Cancer Genet; 2012 Apr; 205(4):156-62. PubMed ID: 22559976
[TBL] [Abstract][Full Text] [Related]
12. Optimization of the MB49 mouse bladder cancer model for adenoviral gene therapy.
Loskog A; Ninalga C; Hedlund T; Alimohammadi M; Malmström PU; Tötterman TH
Lab Anim; 2005 Oct; 39(4):384-93. PubMed ID: 16197705
[TBL] [Abstract][Full Text] [Related]
13. A novel therapeutic vaccine of mouse GM-CSF surface modified MB49 cells against metastatic bladder cancer.
Zhang X; Shi X; Li J; Hu Z; Zhou D; Gao J; Tan W
J Urol; 2012 Mar; 187(3):1071-9. PubMed ID: 22266013
[TBL] [Abstract][Full Text] [Related]
14. MB49 murine urothelial carcinoma: molecular and phenotypic comparison to human cell lines as a model of the direct tumor response to bacillus Calmette-Guerin.
Chen F; Zhang G; Cao Y; Hessner MJ; See WA
J Urol; 2009 Dec; 182(6):2932-7. PubMed ID: 19853870
[TBL] [Abstract][Full Text] [Related]
15. Assessment by M-FISH of karyotypic complexity and cytogenetic evolution in bladder cancer in vitro.
Williams SV; Adams J; Coulter J; Summersgill BM; Shipley J; Knowles MA
Genes Chromosomes Cancer; 2005 Aug; 43(4):315-28. PubMed ID: 15846775
[TBL] [Abstract][Full Text] [Related]
16. Detection of genetic alterations in primary bladder carcinoma with dual-color and multiplex fluorescence in situ hybridization.
Stamouli MI; Panani AD; Ferti AD; Petraki C; Oliver RT; Raptis SA; Young BD
Cancer Genet Cytogenet; 2004 Mar; 149(2):107-13. PubMed ID: 15036885
[TBL] [Abstract][Full Text] [Related]
17. [Molecular genetics of urinary bladder cancer progression].
Sauter G; Simon R; Bubendorf L; Mihatsch M
Verh Dtsch Ges Pathol; 2002; 86():49-56. PubMed ID: 12647351
[TBL] [Abstract][Full Text] [Related]
18. [A simple and efficient method for establishing a mouse model of orthotopic MB49 bladder cancer].
Liang ZK; Zhang L; Hu ZM; Chen Z; Huang X; Shi XH; Tan WL; Gao JM
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Apr; 29(4):627-30. PubMed ID: 19403380
[TBL] [Abstract][Full Text] [Related]
19. [Analyses of chromosomal karyotypes and cytogenetic variations of animal cell lines].
Zhang DL; Li LJ; Xia GT; He XY; Gao BX; Bai XH; Huang GS; Liu SG; Yan LF; Fang FD; Hu CL; Wang LJ; Jiang HH; Feng AM; Zhang GM; An SG; Ren YQ; Guo JM; Hu SX; Fan JX; Niu YL; Song ZJ; Li Y; Fan SJ
Yi Chuan Xue Bao; 2001; 28(4):327-44. PubMed ID: 11329875
[TBL] [Abstract][Full Text] [Related]
20. Combined spectral karyotyping, comparative genomic hybridization, and in vitro apoptyping of a panel of Burkitt's lymphoma-derived B cell lines reveals an unexpected complexity of chromosomal aberrations and a recurrence of specific abnormalities in chemoresistant cell lines.
Karpova MB; Schoumans J; Blennow E; Ernberg I; Henter JI; Smirnov AF; Nordenskjöld M; Fadeel B
Int J Oncol; 2006 Mar; 28(3):605-17. PubMed ID: 16465364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
